Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Oncology
Reference21 articles.
1. Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health. 2015;7:405–14.
2. Ancuta C. Neoangiogenesis in cervical cancer: focus on CD34 assessment. Rom J Morphol Embryol. 2010;51(2):289–97.
3. Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman DH, Diaz-Arrastia CR. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer. Transl Oncol. 2010;3(3):170–5.
4. Steinbeck RG, Heselmeyer KM, Moberger HB, Auer GU. The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma. Acta Oncol. 1995;34(2):171–6.
5. Capobianco G, Marras V, Wenger JM, et al. P16 immunostaining and HPV testing in histological specimens from the uterine cervix. Eur J Gynaecol Oncol. 2013;34(3):227–30.